Need for a personalized approach for muscle invasive bladder cancer: role of tumor biology in response to neoadjuvant chemotherapy

Transl Androl Urol. 2019 Mar;8(Suppl 1):S99-S103. doi: 10.21037/tau.2018.12.04.

Authors

Monika Joshi¹, Joshua I Warrick^{2

3}, Ming Yin⁴, Sheldon L Holder¹, Joseph J Drabick¹

Affiliations

¹ Department of Medicine, Division of Hematology-Oncology, Penn State Cancer Institute, Hershey, PA, USA.
² Department of Pathology, Penn State Health, Hershey, PA, USA.
³ Department of Urology, Penn State Health, Hershey, PA, USA.
⁴ Department of Medicine, Division of Oncology, The Ohio State University, Columbus, Ohio, USA.

No abstract available

Publication types

Editorial
Comment